Core Viewpoint - Jiuan Medical (002432.SZ) expects a net profit attributable to shareholders of 202 million to 235 million yuan for 2025, representing a year-on-year growth of 21.05% to 40.83% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 207 million and 240 million yuan, indicating a growth of 23.18% to 42.81% compared to the previous year [1] Financial Performance - The company achieved a net profit growth compared to the same period last year, primarily driven by strong performance in asset management business in large asset allocation [1] - The company is committed to asset preservation and appreciation while continuously enhancing its risk resistance capabilities [1] Product Demand - The demand for the company's reagent kits, used as regular home screening tools for respiratory viruses, remains stable [1] - The market for home medical health electronic products is also experiencing consistent demand [1]
九安医疗(002432.SZ):预计2025年净利润同比增长21.05%~40.83%